Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

What are the determinants of type of breast surgery following neoadjuvant chemotherapy? An analysis of breast cancer patients among Italian SENONET centers: NEOIMPACT study.

Created on 29 Jun 2026

Authors

A De Luca, M I Amabile, M Tomatis, A Ponti, L Marotti, M Calabrese, C Marchiò, F Puglisi, I Palumbo, C Tinterri, M Taffurelli, L Fortunato, Senonet Collaborative Group

Published in

Breast (Edinburgh, Scotland). Volume 88. Pages 104842. Jun 16, 2026. Epub Jun 16, 2026.

Abstract

Concerns remain regarding determinants of breast-conserving surgery (BCS) following NACT, particularly in presence of a pathologic complete response (pCR).
Retrospective analysis of 65,926 women treated at 26 Italian Breast Centers between 2017 and 2022 using the data-warehouse, SENONET. Clinical and pathological data of patients treated with NACT were analyzed to identify factors influencing surgical decision-making.
A total of 4366 BC patients received NACT, of whom 2008 women (46%) underwent BCS. A non-significant trend over time in the adoption of BCS was observed (p = 0.187). Lower rates of BCS were significantly associated with age ≤49 years, multifocal/multicentric disease, microcalcifications, presence of DCIS, tumor ≥2 cm or cN+ (p < 0.05). A pCR was achieved in 31% of patients but was not associated with higher BCS rates (p = 0.353). Among patients achieving a pCR with either unifocal or multicentric tumor, 283/783 (36%) and 104/117 (89%) women underwent mastectomy, respectively. After mastectomy, 1749/2358 patients (74%) received breast reconstruction, with an increase over time for both an immediate breast reconstruction (IBR) and a nipple-sparing mastectomy approach (p = 0.012). Age <50 years and pCR were significantly associated with IBR (p < 0.001) while cT2+ stage (p = 0.028), cN+ (p < 0.001), and age >70 years (p < 0.001) resulted negatively associated with IBR.
BCS remains underutilized after NACT, and surgical choices continue to be predominantly guided by pre-treatment clinical features rather than tumor response. Even among patients with biologically responsive unicentric tumors and those achieving pCR a significant propensity for mastectomy persists. These findings highlight the urgent need for updated guidelines to reduce unnecessary mastectomies.

PMID:
42365710
Bibliographic data and abstract were imported from PubMed on 29 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement